Investment Research Track Record & Model Portfolio Performance
Evaluate the historical performance of documented AMAAS investment research selections against preserved baselines and major market benchmarks. Fintech Wave Alpha, Bravo, and Charlie are documented model portfolios generated from the Fintech Trades / AMAAS research process. Current constituent prices and benchmark closes on this page are refreshed from end-of-day market data when the Track Record page is requested.
Executive Summary
All three waves show average constituent growth: the arithmetic mean of the individual constituent growth percentages from their documented baselines. Each constituent has equal weight in this percentage, regardless of its baseline share price. Baseline and latest dollar totals are shown separately for reference; they do not determine the displayed average.
The model uses a 12-month forecast horizon. Returns shown here are cumulative since each wave’s baseline, not annualized or fixed 12-month results. Results beyond that horizon provide extended performance context.
Fintech Wave Alpha
Baseline start date: 4/17/2025. Documented constituent baseline total: $1,720.08. Latest constituent closing-price total: $2,562.51.
Major Market Benchmarks
Each benchmark uses the first available closing price on or after this Fintech Wave's baseline start date and the most recent available end-of-day close. Benchmark percentages are supplied by the Track Record data service and represent changes in the benchmark series, rather than an average of the wave’s constituent returns.
Constituent Performance
| Rank | Company | Selection Date | Baseline Price | Latest Value / Original Share | Growth |
|---|---|---|---|---|---|
| 1 |
FEIM
FREQUENCY ELECTRONICS, INC.
|
4/17/2025 | $15.06 |
$71.20
2026-10-14
|
+372.78% |
| 2 |
HOOD
ROBINHOOD MARKETS, INC.
|
4/17/2025 | $34.51 |
$101.08
2026-10-14
|
+192.90% |
| 3 |
PTGX
PROTAGONIST THERAPEUTICS, INC.
|
4/17/2025 | $44.44 |
$136.28
2026-10-14
|
+206.66% |
| 4 |
HWM
HOWMET AEROSPACE INC.
|
4/17/2025 | $112.33 |
$217.54
2026-10-14
|
+93.66% |
| 5 |
ENVA
ENOVA INTERNATIONAL, INC.
|
6/24/2025 | $100.56 |
$174.18
2026-10-14
|
+73.21% |
| 6 |
UI
UBIQUITI INC.
|
4/17/2025 | $273.45 |
$605.51
2026-10-14
|
+121.43% |
| 7 |
VIRT
VIRTU FINANCIAL, INC.
|
4/17/2025 | $35.10 |
$55.48
2026-10-14
|
+58.06% |
| 8 |
WLFC
WILLIS LEASE FINANCE CORPORATION
|
4/17/2025 | $135.52 |
$37.89
2026-10-14
|
-72.04% |
| 9 |
TPB
TURNING POINT BRANDS, INC.
|
4/17/2025 | $54.53 |
$57.70
2026-10-14
|
+5.81% |
| 10 |
EXEL
EXELIXIS, INC.
|
4/17/2025 | $34.57 |
$60.99
2026-10-14
|
+76.42% |
| 11 |
IDCC
InterDigital, Inc.
|
4/17/2025 | $191.31 |
$325.86
2026-10-14
|
+70.33% |
| 12 |
CPRX
CATALYST PHARMACEUTICALS, INC.
Acquired — $31.50 cash per original share; cash held without interest.
|
4/17/2025 | $23.07 |
$31.50
2026-07-15
|
+36.54% |
| 13 |
PRDO
PERDOCEO EDUCATION CORPORATION
|
4/17/2025 | $25.49 |
$33.55
2026-10-14
|
+31.62% |
| 14 |
EAT
BRINKER INTERNATIONAL, INC.
|
4/17/2025 | $135.07 |
$204.24
2026-10-14
|
+51.21% |
| 15 |
ATGE
COVISTA INC.
· current market symbol CVSA
|
4/17/2025 | $98.02 |
$129.48
2026-10-14
|
+32.10% |
| 16 |
HALO
HALOZYME THERAPEUTICS, INC.
|
4/17/2025 | $59.77 |
$116.82
2026-10-14
|
+95.45% |
| 17 |
SYF
SYNCHRONY FINANCIAL
|
10/30/2025 | $74.41 |
$71.72
2026-10-14
|
-3.62% |
| 18 |
CALM
CAL-MAINE FOODS, INC.
|
4/17/2025 | $92.29 |
$63.19
2026-10-14
|
-31.53% |
| 19 |
ADMA
ADMA BIOLOGICS, INC.
|
4/17/2025 | $18.01 |
$10.34
2026-10-14
|
-42.59% |
| 20 |
CVNA
CARVANA CO.
|
4/17/2025 | $162.57 |
$57.96
2026-10-14
|
-64.35% |
Fintech Wave Bravo
Baseline start date: 9/19/2025. Documented constituent baseline total: $858.92. Latest constituent closing-price total: $1,138.52.
Major Market Benchmarks
Each benchmark uses the first available closing price on or after this Fintech Wave's baseline start date and the most recent available end-of-day close. Benchmark percentages are supplied by the Track Record data service and represent changes in the benchmark series, rather than an average of the wave’s constituent returns.
Constituent Performance
| Rank | Company | Selection Date | Baseline Price | Latest Value / Original Share | Growth |
|---|---|---|---|---|---|
| 1 |
ACMR
ACM RESEARCH, INC.
|
9/19/2025 | $35.89 |
$61.12
2026-10-14
|
+70.30% |
| 2 |
NUTX
NUTEX HEALTH INC.
|
9/19/2025 | $96.11 |
$196.91
2026-10-14
|
+104.88% |
| 3 |
DAVE
DAVE INC.
|
12/22/2025 | $218.01 |
$356.80
2026-10-14
|
+63.66% |
| 4 |
ESP
ESPEY MFG. & ELECTRONICS CORP.
|
12/22/2025 | $45.32 |
$56.58
2026-10-14
|
+24.85% |
| 5 |
PTCT
PTC THERAPEUTICS, INC.
|
9/19/2025 | $60.48 |
$59.67
2026-10-14
|
-1.34% |
| 7 |
NRIM
NORTHRIM BANCORP, INC.
|
10/30/2025 | $22.10 |
$24.11
2026-10-14
|
+9.10% |
| 8 |
STRT
STRATTEC SECURITY CORPORATION
|
9/19/2025 | $70.45 |
$60.94
2026-10-14
|
-13.50% |
| 9 |
FHI
FEDERATED HERMES, INC.
|
9/19/2025 | $52.70 |
$54.91
2026-10-14
|
+4.19% |
| 10 |
SYF
SYNCHRONY FINANCIAL
|
9/19/2025 | $76.59 |
$71.72
2026-10-14
|
-6.36% |
| 11 |
HCI
HCI GROUP, INC.
|
9/19/2025 | $181.27 |
$195.76
2026-10-14
|
+7.99% |
Fintech Wave Charlie
Baseline start date: 11/28/2025. Documented constituent baseline total: $814.96. Latest constituent closing-price total: $1,081.85.
Major Market Benchmarks
Each benchmark uses the first available closing price on or after this Fintech Wave's baseline start date and the most recent available end-of-day close. Benchmark percentages are supplied by the Track Record data service and represent changes in the benchmark series, rather than an average of the wave’s constituent returns.
Constituent Performance
| Rank | Company | Selection Date | Baseline Price | Latest Value / Original Share | Growth |
|---|---|---|---|---|---|
| 1 |
ACMR
ACM RESEARCH, INC.
|
11/28/2025 | $32.87 |
$61.12
2026-10-14
|
+85.94% |
| 2 |
FEIM
FREQUENCY ELECTRONICS, INC.
|
11/28/2025 | $28.64 |
$71.20
2026-10-14
|
+148.60% |
| 3 |
C
CITIGROUP INC.
|
11/28/2025 | $102.50 |
$122.27
2026-10-14
|
+19.29% |
| 4 |
PTCT
PTC THERAPEUTICS, INC.
|
11/28/2025 | $60.48 |
$59.67
2026-10-14
|
-1.34% |
| 5 |
FCAP
FIRST CAPITAL, INC.
|
11/28/2025 | $49.40 |
$61.77
2026-10-14
|
+25.04% |
| 6 |
NUTX
NUTEX HEALTH INC.
|
11/28/2025 | $112.80 |
$196.91
2026-10-14
|
+74.57% |
| 7 |
AMG
AFFILIATED MANAGERS GROUP, INC.
|
11/28/2025 | $267.60 |
$372.17
2026-10-14
|
+39.08% |
| 8 |
NCSM
NCS MULTISTAGE HOLDINGS, INC.
Converted to WFRD — 0.5537 shares per original NCSM share (default election).
|
11/28/2025 | $37.44 |
$41.78
2026-10-14
|
+11.58% |
| 9 |
NC
NACCO INDUSTRIES, INC.
|
11/28/2025 | $47.98 |
$34.02
2026-10-14
|
-29.10% |
| 10 |
STRT
STRATTEC SECURITY CORPORATION
|
11/28/2025 | $75.25 |
$60.94
2026-10-14
|
-19.02% |
Methodology Context
Corporate actions are included in constituent holding values, individual growth percentages, and dollar totals. The headline wave return is the arithmetic mean of all constituent growth percentages; it is not the return of the one-share-per-selection portfolio. A full average is withheld when any constituent return is unavailable. CPRX is carried as $31.50 cash per original share from July 15, 2026, without interest or reinvestment. NCSM is modeled using the default non-election conversion of 0.5537 WFRD shares per original share from September 1, 2026; fractional shares are valued proportionally. These values are cash proceeds or successor-share equivalents, rather than current quotes for the original tickers. Original baseline prices are preserved.
Sources: Nasdaq CPRX merger notice · Nasdaq NCSM merger notice.
Amaas evaluates publicly traded equities using a structured research workflow that combines quantitative scoring, financial statement analysis, valuation context, market sentiment, projected growth, and macroeconomic conditions. The Fintech Wave model portfolios are historical examples of this research process applied at specific points in time.
Research & Performance Disclosure
Amaas provides research, analysis, and decision-support information only. Fintech Wave model portfolio results are historical research examples and should not be interpreted as personalized investment advice, a recommendation to buy or sell securities, or a guarantee of future performance. Past performance is not indicative of future results. Benchmark comparisons are provided for context. Constituent baseline prices are the documented selection prices in the Fintech Wave records; latest prices and benchmark comparisons use the most recent available end-of-day market data.